Exicure to Present at Upcoming Scientific Conferences
October 28 2021 - 7:00AM
Business Wire
Exicure, Inc.® (NASDAQ: XCUR), a pioneer in gene regulatory and
immunotherapeutic drugs utilizing spherical nucleic acid (SNA™)
technology, today announced presentations at the following
scientific conferences during the month of November:
TIDES EU Title: "Development of Spherical Nucleic Acids
Targeting SCN9A For the Treatment of Neuropathic Pain" Presented
by: Bart Anderson, Senior Director, R&D Date: November 16, 2021
Time: 8:45am CET / 1:45am U.S. CST
Neuroscience 2021 (The Society for Neuroscience) Poster
1: "Spherical Nucleic Acids Targeting FXN Induce Frataxin
Expression in Models of Friedreich’s Ataxia" Presented by: Grant
Corbett, Group Lead, Neuroscience Poster 2: "Biodistribution of
Spherical Nucleic Acids in the Mouse CNS Following ICV, ICM and IT
Delivery" Presented by: Lauren Moore, Senior Scientist,
Neuroscience November 8-11, 2021
About Exicure, Inc.
Exicure, Inc. is a clinical-stage biotechnology company
developing therapeutics for neurology, immuno-oncology,
inflammatory diseases and other genetic disorders based on its
proprietary Spherical Nucleic Acid, or SNA technology. Exicure
believes that its proprietary SNA architecture has distinct
chemical and biological properties that may provide advantages over
other nucleic acid therapeutics and may have therapeutic potential
to target diseases not typically addressed with other nucleic acid
therapeutics. Exicure is in preclinical development of XCUR-FXN, a
lipid-nanoparticle SNA–based therapeutic candidate, for the
intrathecal treatment of Friedreich’s ataxia (FA). Exicure’s
therapeutic candidate cavrotolimod (AST-008) is in a Phase 1b/2
clinical trial in patients with advanced solid tumors. Exicure is
based in Chicago, IL and in Cambridge, MA. www.exicuretx.com
View source
version on businesswire.com: https://www.businesswire.com/news/home/20211028005075/en/
Media: Karen Sharma MacDougall 781-235-3060
ksharma@macbiocom.com
Exicure (NASDAQ:XCUR)
Historical Stock Chart
From Jun 2024 to Jul 2024
Exicure (NASDAQ:XCUR)
Historical Stock Chart
From Jul 2023 to Jul 2024